I understand what you are suggesting, but you have to remember that this is a capital-intensive business. DNRG needs to raise money in order to deliver on the promise to make money in this business for all stakeholders, including us shareholders. There are two ways to do this - through equity financing, or through debt financing.
Either way, there will surely be dilution. Either way, the dilution will be offset by the funds secured for business development and growth.
I am confident that DNRG is working diligently on putting the pieces together to tell the story and we will be hearing very soon what their recent progress has been.
The opportunity is tremendous, as we all know. That's why we invested. The initiatives are strong with very good backing politically and financially, and momentum is growing rapidly. In my opinion, the rapid growth potential is on par with pharmaceutical and biotech, but with much less time and risk.
We just need to sit tight until we get the news - or sell and find a better investment if not willing to wait and take the risk that DNRG failed to accomplish anything with any substance over the past few months. I'm content to hold. Heck, we haven't even heard what came of the visit to Africa or DNRG's own financing initiatives.
I like that we have not been seeing piecemeal PR's released simply to pump up or even prop up the stock. I think DNRG is putting together a more complete and cohesive story to cover the bases, and I believe it's worth waiting for.
